Literature DB >> 21355639

Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder.

Helen Blair Simpson1, Michael J Maher2, Yuanjia Wang3, Yuanyuan Bao4, Edna B Foa5, Martin Franklin5.   

Abstract

OBJECTIVE: To examine the effects of patient adherence on outcome from exposure and response prevention (EX/RP) therapy in adults with obsessive-compulsive disorder (OCD).
METHOD: Thirty adults with OCD were randomized to EX/RP (n = 15) or EX/RP augmented by motivational interviewing strategies (n = 15). Both treatments included 3 introductory sessions and 15 exposure sessions. Because there were no significant group differences in adherence or outcome, the groups were combined to examine the effects of patient adherence on outcome. Independent evaluators assessed OCD severity using the Yale-Brown Obsessive Compulsive Scale. Therapists assessed patient adherence to between-session EX/RP assignments at each session using the Patient EX/RP Adherence Scale (PEAS). Linear regression models were used to examine the effects of PEAS scores on outcome, adjusting for baseline severity. The relationship between patient adherence and other predictors of outcome was explored using structural equation modeling.
RESULTS: Higher average PEAS ratings significantly predicted lower posttreatment OCD severity in intent-to-treat and completer samples. PEAS ratings in early sessions (5-9) also significantly predicted posttreatment OCD severity. The effects of other significant predictors of outcome in this sample (baseline OCD severity, hoarding subtype, and working alliance) were fully mediated by patient adherence.
CONCLUSIONS: Patient adherence to between-session EX/RP assignments significantly predicted treatment outcome, as did early patient adherence and change in early adherence. Patient adherence mediated the effects of other predictors of outcome. Future research should develop interventions that increase adherence and then test whether increasing adherence improves outcome. If effective, these interventions could then be used to personalize care. (c) 2011 APA, all rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21355639      PMCID: PMC3891521          DOI: 10.1037/a0022659

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  18 in total

1.  Psychometric properties of the credibility/expectancy questionnaire.

Authors:  G J Devilly; T D Borkovec
Journal:  J Behav Ther Exp Psychiatry       Date:  2000-06

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Early compliance and other factors predicting outcome of exposure for obsessive-compulsive disorder.

Authors:  L A De Araujo; L M Ito; I M Marks
Journal:  Br J Psychiatry       Date:  1996-12       Impact factor: 9.319

4.  Emotional processing of fear: exposure to corrective information.

Authors:  E B Foa; M J Kozak
Journal:  Psychol Bull       Date:  1986-01       Impact factor: 17.737

5.  The Brown Assessment of Beliefs Scale: reliability and validity.

Authors:  J L Eisen; K A Phillips; L Baer; D A Beer; K D Atala; S A Rasmussen
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

6.  Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy.

Authors:  E de Haan; P van Oppen; A J van Balkom; P Spinhoven; K A Hoogduin; R Van Dyck
Journal:  Acta Psychiatr Scand       Date:  1997-11       Impact factor: 6.392

7.  Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder.

Authors:  M J Maher; J D Huppert; H Chen; N Duan; E B Foa; M R Liebowitz; H B Simpson
Journal:  Psychol Med       Date:  2010-04-26       Impact factor: 7.723

8.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

9.  The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; P Delgado; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.

Authors:  David F Tolin; Nicholas Maltby; Gretchen J Diefenbach; Scott E Hannan; Patrick Worhunsky
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

View more
  34 in total

1.  Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Jonathan D Huppert; Shawn Cahill; Michael J Maher; Carmen P McLean; James Bender; Sue M Marcus; Monnica T Williams; Jamie Weaver; Donna Vermes; Page E Van Meter; Carolyn I Rodriguez; Mark Powers; Anthony Pinto; Patricia Imms; Chang-Gyu Hahn; Raphael Campeas
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

2.  What matters more? Common or specific factors in cognitive behavioral therapy for OCD: Therapeutic alliance and expectations as predictors of treatment outcome.

Authors:  Asher Y Strauss; Jonathan D Huppert; H Blair Simpson; Edna B Foa
Journal:  Behav Res Ther       Date:  2018-03-27

3.  Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?

Authors:  Michael G Wheaton; Hanga Galfalvy; Shari A Steinman; Melanie M Wall; Edna B Foa; H Blair Simpson
Journal:  Behav Res Ther       Date:  2016-07-29

4.  Reducing recidivism and symptoms in emerging adults with serious mental health conditions and justice system involvement.

Authors:  Maryann Davis; Ashli J Sheidow; Michael R McCart
Journal:  J Behav Health Serv Res       Date:  2015-04       Impact factor: 1.505

5.  Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.

Authors:  Laurie J Zandberg; Yinyin Zang; Carmen P McLean; Rebecca Yeh; Helen Blair Simpson; Edna B Foa
Journal:  Behav Res Ther       Date:  2015-03-13

6.  Patient adherence to cognitive-behavioral therapy predicts long-term outcome in obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Sue M Marcus; Allan Zuckoff; Martin Franklin; Edna B Foa
Journal:  J Clin Psychiatry       Date:  2012-09       Impact factor: 4.384

7.  The development and validation of the Memory Support Rating Scale.

Authors:  Jason Y Lee; Frank C Worrell; Allison G Harvey
Journal:  Psychol Assess       Date:  2015-09-21

8.  Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.

Authors:  Michael G Wheaton; Marina Gershkovich; Thea Gallagher; Edna B Foa; H Blair Simpson
Journal:  Depress Anxiety       Date:  2018-02-02       Impact factor: 6.505

9.  Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.

Authors:  David Pagliaccio; Rachel Middleton; Dianne Hezel; Shari Steinman; Ivar Snorrason; Marina Gershkovich; Raphael Campeas; Anthony Pinto; Page Van Meter; H Blair Simpson; Rachel Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

10.  Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?

Authors:  Jennifer M Park; Brent J Small; Daniel A Geller; Tanya K Murphy; Adam B Lewin; Eric A Storch
Journal:  J Child Fam Stud       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.